Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artículo Open Access |
| Veröffentlicht: |
Wiley
2024
|
| Schlagworte: | |
| Online-Zugang: | https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6258 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1867014917029101568 |
|---|---|
| author | Anke Augspach Mark A Rubin |
| author_facet | Anke Augspach Mark A Rubin Anke Augspach Mark A Rubin |
| collection | Wiley Open Access |
| contents | Upcycling HOXB13 : enhancing prostate cancer detection with a novel antibody † Anke Augspach Mark A Rubin The Journal of Pathology Abstract Prostate cancer is one of the most prevalent and, upon metastasis, deadliest cancers in men. Timely identification is essential for effective treatment. Furthermore, accurate determination of prostatic origin is crucial for personalized therapy once the cancer has spread. However, current prostate cancer screening methods are lacking. A recent article in The Journal of Pathology addresses this issue by utilizing an improved antibody to reevaluate HOXB13 as a lineage marker for prostate cancer. The study's findings support the concept that, despite decreased expression in advanced prostate cancer, HOXB13 remains highly suitable for determining prostatic origin due to its androgen receptor independence, high specificity, and sensitivity. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.6258 http://creativecommons.org/licenses/by/4.0/ |
| doi_str_mv | 10.1002/path.6258 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_path_6258 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Upcycling HOXB13 : enhancing prostate cancer detection with a novel antibody † Anke Augspach Mark A Rubin The Journal of Pathology Upcycling HOXB13 : enhancing prostate cancer detection with a novel antibody † Anke Augspach Mark A Rubin The Journal of Pathology Abstract Prostate cancer is one of the most prevalent and, upon metastasis, deadliest cancers in men. Timely identification is essential for effective treatment. Furthermore, accurate determination of prostatic origin is crucial for personalized therapy once the cancer has spread. However, current prostate cancer screening methods are lacking. A recent article in The Journal of Pathology addresses this issue by utilizing an improved antibody to reevaluate HOXB13 as a lineage marker for prostate cancer. The study's findings support the concept that, despite decreased expression in advanced prostate cancer, HOXB13 remains highly suitable for determining prostatic origin due to its androgen receptor independence, high specificity, and sensitivity. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.6258 http://creativecommons.org/licenses/by/4.0/ |
| title | Upcycling HOXB13 : enhancing prostate cancer detection with a novel antibody † |
| topic | The Journal of Pathology |
| url | https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6258 |